Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

This study has been completed.
Information provided by (Responsible Party):
Celgene Corporation Identifier:
First received: March 22, 2005
Last updated: March 30, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2006
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)